全球介入神經放射學市場 - 2023-2030

概述

全球介入神經放射學市場在 2022 年達到 19 億美元，預計到 2030 年將達到 29 億美元，2023-2030 年預測期間年複合成長率為 5.8%。

介入神經放射治療是通過插入腹股溝區域的微導管來完成的，並在 X 射線引導下穿過通向大腦的血管。介入神經放射科醫生目前採用微創手術來完成多種治療，包括通過將血栓溶解藥物直接輸送到阻塞部位來治療中風；動脈瘤治療，將鉑金彈簧圈插入動脈瘤隆起處，以防止血栓形成和破裂；以及通過向骨折的椎骨中註入水泥來加固骨骼的脊柱治療。

介入神經放射學技術通常使我們能夠進入手術難以到達的大腦和脊柱區域。由於手術是微創的，因此住院時間和康復期通常較短。在許多情況下，它們還降低了併發症和感染的風險

此外，全球介入神經放射學市場受到多種因素的推動，例如人口逐漸老齡化、對微創手術的需求不斷增加以及腦動脈瘤患病率的上升。然而，栓塞線圈的高成本和熟練專業人員的缺乏是阻礙市場成長的主要因素。

動力學

腦動脈瘤患病率上升

腦動脈瘤患病率的上升是預測期內幫助市場成長的關鍵因素之一。例如，根據 NCBI 發表的一篇關於腦動脈瘤的文章，全球範圍內腦動脈瘤的患病率約為 3.2%，平均年齡為 50 歲，總體性別比例為 1:1。這一比例在 50 歲後發生顯著變化，女性比例不斷增加，接近 2:1，這被認為是由於循環雌激素減少導致血管組織膠原蛋白含量減少。導致 SAH 的破裂率約為每 100,000 人中有 10 人發生。

在芬蘭人和日本人等某些人群中這一比例更高。然而，這並不是因為這些人群中動脈瘤的患病率較高。動脈瘤性蛛網膜下腔出血的總死亡率被認為佔全因死亡的 0.4% 至 0.6%，其中已知破裂的患者死亡率約為 20%，發病率高達 30% 至 40%。

技術進步的崛起

顛覆性技術將繼續發展，並改變介入神經放射學工作的執行方式。提高治療效果、縮短護理時間、降低成本並實現更好的以患者為中心的結果的改變是非常可取的。

其中一項技術是機器人輔助介入神經放射學，這是介入神經放射學和生物醫學機器人學交叉的一個新興領域。血管內機器人可以實現操作自動化，以減少手術時間並提高安全性，減少與電離輻射相關的職業危害，並擴大護理網路以縮小接受神經干涉的地理差距。

大學健康網路的多倫多西部醫院使用遠程操作系統進行了首例人類機器人輔助神經介入手術。這項開創性的手術由 Vitor Mendes Pereira 博士領導，旨在改善中風治療的可及性並降低動脈瘤破裂的風險。

該機器人系統是世界上唯一能夠進行此類神經介入手術的系統。手術過程中，佩雷拉博士通過數位控制引導機械臂，以毫米級精度引導微導管穿過腦血管，並部署線圈，限制流向動脈瘤的血液。

放射科醫生短缺

放射科醫生的短缺是預測期內阻礙市場成長的關鍵因素之一。市場成長的下降將導致醫療機構猶豫是否投資用於介入神經放射學的昂貴設備。

放射科醫生的短缺對患者的治療結果產生了深遠的影響。 “及時、準確的診斷在確定適當的治療方案方面發揮著關鍵作用，尤其是在危重情況下。延遲或不準確的診斷可能會導致患者安全受損、住院時間延長和醫療費用增加。此外，我們有限的醫療資源也給我們帶來了巨大的負擔。”放射科工作人員可能會導致倦怠和疲勞，可能會影響報告的整體品質。

目錄

第 1 章：方法和範圍

• 研究方法論
• 報告的研究目的和範圍

第 2 章：定義和概述

第 3 章：執行摘要

• 按設備類型分類
• 按應用程式片段
• 最終用戶的片段
• 按地區分類

第 4 章：動力學

• 影響因素
  • 動力
    • 腦動脈瘤患病率上升
    • 技術進步的崛起
  • 限制
    • 放射科醫生短缺
  • 機會
    • 新興市場產品發布數量增加
  • 影響分析

第 5 章：行業分析

• 波特五力分析
• 供應鏈分析
• 定價分析
• 監管分析
• 俄烏戰爭影響分析
• DMI 意見

第 6 章：COVID-19 分析

• COVID-19 分析
  • 新冠疫情爆發前的情景
  • 新冠疫情期間的情景
  • 新冠疫情后的情景
• COVID-19 期間的定價動態
• 供需譜
• 疫情期間政府與市場相關的舉措
• 製造商戰略舉措
• 結論

第 7 章：按設備類型

• 微導管
• 神經血管栓塞和纏繞輔助裝置
• 栓塞彈簧圈
• 分流裝置
• 液體栓塞劑
• 配件
• 微導絲

第 8 章：按應用

• 腦動脈瘤
• 顱內動脈粥樣硬化腫瘤
• 急性缺血性中風
• 其他

第 9 章：最終用戶

• 醫院
• 門診手術中心
• 診斷中心

第 10 章：按地區

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 歐洲其他地區
• 南美洲
  • 巴西
  • 阿根廷
  • 南美洲其他地區
• 亞太
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 亞太其他地區
• 中東和非洲

第 11 章：競爭格局

• 競爭場景
• 市場定位/佔有率分析
• 併購分析

第 12 章：公司簡介

• Balt Extrusion
• 公司簡介
• 產品組合和描述
• 財務概覽
• 主要進展
• Merit Medical Systems
• Terumo Corporation
• Medtronic
• Penumbra, Inc.
• Mediterra
• Stryker
• Boston Scientific Corporation
• MicroPort Scientific Corporation
• MicroVention Inc

第 13 章：附錄

Overview

Global Interventional Neuroradiology Market reached US$ 1.9 billion in 2022 and is expected to reach US$ 2.9 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2023-2030.

Interventional neuroradiology therapies are accomplished through microcatheters inserted in the groin area and, under X-ray guidance, threaded through the blood vessels leading into the brain. Interventional neuroradiologists currently employ minimally invasive procedures to accomplish a wide variety of treatments including stroke treatment by delivering clot-busting drugs directly to the site of the blockage; aneurysm therapy by inserting platinum coils into the aneurysm bulge to prevent clotting and rupture; and spinal treatments by injecting cement into a fractured vertebra to reinforce the bone.

Interventional neuroradiology techniques often allow us access to areas of the brain and spine that are surgically difficult to reach. Because the procedures are minimally invasive, hospital stays and recovery periods are normally shorter. In many cases, they also pose a lower risk for complications and infection

Furthermore, the global interventional neuroradiology market is driven by various factors like a progressively ageing population, increasing demand for minimally invasive procedures and a rise in the prevalence of the cerebral aneurysms. However, the high cost of embolization coils and the dearth of skilled professionals are the major factors hindering the market growth.

Dynamics

Rise in the Prevalence of Cerebral Aneurysms

The rise in the prevalence of cerebral aneurysms is one of the key factors that helps the market to grow during the forecast period. For instance, according to an article published on cerebral aneurysms in NCBI, the worldwide prevalence of cerebral aneurysms is approximately 3.2%, with a mean age of 50 and an overall 1:1 gender ratio. This ratio changes significantly after age 50, with an increasing female predominance approaching 2:1, thought to be due to decreased circulating estrogen causing a reduction in the collagen content of the vascular tissue. The rate of rupture causing SAH is about 10 per 100,000.

This is higher in certain populations such as the Finnish and Japanese. However, this is not due to a higher prevalence of aneurysms in these populations. The overall mortality due to aneurysmal SAH is considered to be 0.4 to 0.6% of all-cause deaths, with an approximate 20% mortality and an additional 30 to 40% morbidity in patients with known rupture.

Rise in the Technological Advancements

Disruptive technologies will continue to be developed and evolve the way interventional neuroradiology work is performed. Changes that improve treatment efficacy, shorten the duration of care, reduce costs and allow better patient-centred outcomes are highly desirable.

One of the technologies is Robotic-assisted interventional neuroradiology which is an emerging field at the intersection of interventional neuroradiology and biomedical robotics. Endovascular robotics can automate manoeuvres to reduce procedure times and increase safety, reduce occupational hazards associated with ionizing radiations, and expand networks of care to reduce gaps in geographic access to neuro interventions.

The University Health Network's Toronto Western Hospital has performed the first-in-human robot-assisted neuro-interventional procedure using a remote operation system. This groundbreaking procedure, led by Dr. Vitor Mendes Pereira, aims to improve stroke treatment access and reduce the risk of aneurysm rupture.

The robotic system is the only one in the world capable of this type of neuro-interventional procedure. The procedure involved Dr Pereira leading the robotic arm through digital controls, guiding a microcatheter with millimetric precision through brain vessels and deploying a coil, limiting blood flow to the aneurysm.

Shortage of Radiologists

A shortage of Radiologists is one of the key factors that hamper the market growth during the forecast period. The decline in market growth will result in healthcare facilities hesitating to invest in expensive devices that are used in interventional neuroradiology.

The shortage of radiologists has far-reaching consequences for patient outcomes. "Timely and accurate diagnoses play a pivotal role in determining the appropriate course of treatment, especially in critical conditions. Delayed or inaccurate diagnoses may lead to compromised patient safety, prolonged hospital stays, and increased healthcare costs. Furthermore, the immense burden on our limited radiology workforce can lead to burnout and fatigue, potentially compromising the overall quality of reporting.

Segment Analysis

The global interventional neuroradiology market is segmented based on device type, application, end-user and region.

The Microcatheters Segment From the Device Type Segment Accounted For Approximately 41.7% of Interventional Neuroradiology Share

The microcatheters segment from the device type segment accounted for 41.7% and it is expected to be dominated during the forecast period. Microcatheters are small in size which helps to reduce the risk of vessel injury during the catheterization which helps the procedure to be processed safely during the timeline.

Microcatheters are soft and floppy as they are designed to be the least traumatic. Once a stable position is achieved with a guide catheter or distal access catheter, microcatheters are then advanced to the exact site in the cerebral vasculature. They have different lengths, diameters, stiffness, tractability, and radio-opaque markers, and some of them are even detachable for use in vascular malformations.

For instance, in March 2022 Guerbet announced it will more than double its line of microcatheters and launch a new line of guidewires, resulting in a broad range of interventional imaging and embolization solutions becoming available.

The company obtained its original offering of 18 references of SeQure and DraKon microcatheters as part of its acquisition of Accurate Medical Therapeutics in 2018. It received the CE mark in April 2019 and was US Food and Drug Administration (FDA) in 2018. Guerbet now expands the portfolio, adding 20 versions for a total of 38, and launching a new line of Axessio guidewires with two diameters.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period, owing to factors like new device launches by key players, strategic partnerships within the companies, Heavy utilization of medical imaging technologies, advanced healthcare infrastructure, regulatory framework, patient awareness, market competitiveness will drive the region to be largest during the forecast period.

For instance, in February 2023 RAYUS Radiology, a leading national provider of advanced diagnostic and interventional medical imaging services, announced the renewal of its partnerships with US Ski & Snowboard, US Speedskating and USA Bobsled/Skeleton and will continue to serve as an official Medical Provider for all three organizations and the elite athletes they represent.

Competitive Landscape

The major global players in the market include: Balt Extrusion, Merit Medical Systems, Terumo Corporation, Medtronic, Penumbra, Inc., Mediterra, Stryker, Boston Scientific Corporation, Micro Port Scientific Corporation, MicroVention Inc. and others.

COVID-19 Impact Analysis

The COVID-19 pandemic has disrupted healthcare on an unprecedented scale. Covid had a minimal impact on the global neuroradiology market where neuro interventions were among the least affected, as most of these procedures fall under emergencies such as stroke, SAH, and intracerebral haemorrhage. neurointerventional procedures such as stroke thrombectomy and endovascular therapy for ruptured aneurysms increased marginally.

Moreover, Difficulties in providing essential/post-sales assistance due to lockdowns have degraded interventional neuroradiology products to end-users. Thus, the pandemic is not expected to have long-term effects on the primary growth drivers or end-users in the interventional neuroradiology market.

By Device Type

• Microcatheters
• Neurovascular Embolization & Coiling Assist Devices
• Embolic Coils
• Flow Diversion Devices
• Liquid Embolic Agents
• Accessories
• Micro guidewires

By Disease

• Cerebral Aneurysms
• Intra-cranial Atherosclerotic Tumors
• Acute Ischemic Strokes
• Other Diseases

End- User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

By Region

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific

• Middle East and Africa

Key Developments

• In June 2023 Adept Medical announced the launch of the Head Immobilizer-a radiolucent support for a range of interventional radiology (IR) and neuroradiology procedures. Now commercially available, the positioning device can help mitigate the costs of retakes, from reducing the amount of mid-procedure interventions caused by head movement in awake patients, to enabling interventionists to consider conscious sedation as an option, as well as minimizing patient exposure to radiation.
• In October 2022 RANZCR formally launched the Standards of Practice for Interventional Radiology and Interventional Neuroradiology at the 72nd Annual Scientific Meeting (ASM) in Adelaide. Applicable to all interventional radiology (IR) and interventional neuroradiology (INR) practices across Australia and New Zealand, these are the first comprehensive standards for the safe and effective preparation, delivery and follow-up of IR and INR services.
• In June 2022, Sheikh Shakhbout Medical City (SSMC), one of the UAE's largest hospitals and a joint-venture partnership between Abu Dhabi Health Services Company (SEHA) and Mayo Clinic, established a new state-of-the-art, Biplane Angio Suite for the diagnosis and treatment of ischemic strokes. The brand-new service is under the Division of Interventional Neuroradiology which is part of the Clinical Imaging department.

Why Purchase the Report?

• To visualize the global interventional neuroradiology market segmentation based on device type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global interventional neuroradiology market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global interventional neuroradiology market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Device Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the Prevalence of Cerebral Aneurysms
    • 4.1.1.2. Rise in the Technological Advancements
  • 4.1.2. Restraints
    • 4.1.2.1. Shortage of Radiologists
  • 4.1.3. Opportunity
    • 4.1.3.1. Rise in the Product Launches in Emerging Markets
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Russia-Ukraine War Impact Analysis
• 5.6. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Device Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 7.1.2. Market Attractiveness Index, By Device Type
• 7.2. Microcatheters*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Neurovascular Embolization & Coiling Assist Devices
• 7.4. Embolic Coils
• 7.5. Flow Diversion Devices
• 7.6. Liquid Embolic Agents
• 7.7. Accessories
• 7.8. Microguidewires

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cerebral Aneurysms *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Intra-cranial Atherosclerotic Tumors
• 8.4. Acute Ischemic Strokes
• 8.5. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals *
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Diagnostic Centers

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Balt Extrusion *
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Merit Medical Systems
• 12.3. Terumo Corporation
• 12.4. Medtronic
• 12.5. Penumbra, Inc.
• 12.6. Mediterra
• 12.7. Stryker
• 12.8. Boston Scientific Corporation
• 12.9. MicroPort Scientific Corporation
• 12.10. MicroVention Inc

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us